Related Experiment Videos

Role of D-dimer in predicting mortality in patients with community-acquired pneumonia

Desa Nastasijević Borovac1, Tatjana Radjenović Petković, Tatjana Pejčić

  • 1Clinic for Lung Diseases, Clinical Center Niš, Knez Selo¹, School of Medicine, University of Niš, Niš²; Serbia.

Abstract

Insights

D-dimer levels in community-acquired pneumonia (CAP) patients correlate with disease severity and mortality risk. While D-dimer showed strong predictive value, it was comparable to the Pneumonia Severity Index (PSI) for mortality prediction.

Area of Science:

  • Medical research
  • Clinical diagnostics
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) poses a significant health risk, necessitating accurate prognostic markers.
  • Standard biomarkers like white blood cell (WBC) count and C-reactive protein (CRP) have limitations in predicting CAP severity and mortality.
  • The role of coagulation markers, specifically D-dimer, in assessing CAP prognosis requires further investigation.

Purpose of the Study:

  • To evaluate the predictive capability of D-dimer for mortality risk in patients with CAP.
  • To compare the efficacy of D-dimer against standard biomarkers (WBC, CRP) and the Pneumonia Severity Index (PSI) in predicting CAP mortality.
  • To investigate the correlation between D-dimer levels and CAP severity.

Main Methods:

  • Analysis of WBC, CRP, and D-dimer levels in 129 CAP patients.
  • Classification of patients into severity groups (PSI I-V) and survival/non-survival groups.
  • Statistical analysis to determine correlations and predictive values (sensitivity, specificity, AUC) for D-dimer and PSI in mortality prediction.

Main Results:

  • WBC and CRP levels did not correlate with CAP severity or mortality risk.
  • Plasma D-dimer showed a significant positive correlation with CAP severity (r=0.4993, p<0.001).
  • Non-surviving patients exhibited significantly higher D-dimer levels compared to survivors (p<0.001). D-dimer demonstrated high sensitivity (0.84) and specificity (0.86) for mortality prediction (AUC=0.859).
  • The Pneumonia Severity Index (PSI) also showed strong mortality prediction (AUC=0.868), with no statistically significant difference compared to D-dimer (p=0.9005).

Conclusions:

  • Coagulation abnormalities, indicated by elevated D-dimer, are associated with severe infections, particularly in older patients with comorbidities.
  • Plasma D-dimer is a more effective predictor of CAP severity and mortality risk than standard inflammatory markers.
  • D-dimer offers comparable mortality prediction to the PSI score in CAP patients, highlighting its potential clinical utility.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
756
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482